Clindamycin palmitate hydrochloride: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__")
 
No edit summary
 
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Clindamycin palmitate hydrochloride}}
{{CMG}}; {{AE}} {{AK}}
'''''For patient information, click <u>[[Clindamycin palmitate hydrochloride (patient information)|here]]</u>'''''.
==Overview==
Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel).
==Category==
[[Lincosamides]]
==US Brand Names==
CLEOCIN HYDROCHLORIDE®
==FDA Package Insert==
'''  [[Clindamycin palmitate hydrochloride description|Description]]'''
'''| [[Clindamycin palmitate hydrochloride clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Clindamycin palmitate hydrochloride microbiology|Microbiology]]'''
'''| [[Clindamycin palmitate hydrochloride indications and usage|Indications and Usage]]'''
'''| [[Clindamycin palmitate hydrochloride contraindications|Contraindications]]'''
'''| [[Clindamycin palmitate hydrochloride warnings|Warnings]]'''
'''| [[Clindamycin palmitate hydrochloride precautions|Precautions]]'''
'''| [[Clindamycin palmitate hydrochloride adverse reactions|Adverse Reactions]]'''
'''| [[Clindamycin palmitate hydrochloride overdosage|Overdosage]]'''
'''| [[Clindamycin palmitate hydrochloride dosage and administration|Dosage and Administration]]'''
'''| [[Clindamycin palmitate hydrochloride how supplied|How Supplied]]'''
'''| [[Clindamycin palmitate hydrochloride labels and packages|Labels and Packages]]'''
==References==
{{Reflist|2}}
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf
[[Category:Antibiotics]]
[[Category:Wikinfect]]__NOTOC__

Latest revision as of 17:34, 9 January 2014

Clindamycin palmitate hydrochloride
CLINDAMYCIN PALMITATE HYDROCHLORIDE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information, click here.

Overview

Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel).

Category

Lincosamides

US Brand Names

CLEOCIN HYDROCHLORIDE®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf